Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Knipper

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Chirurgie (Heidelberg, Germany)|September 16, 2022
[56/m-Dysphagia and loss of weight : Preparation for the medical specialist examination: part 11]Karl Knipper, Thomas Schmidt, Christiane J Bruns
Chirurgie (Heidelberg, Germany)|January 26, 2023
[Hereditary diffuse gastric cancer]Karl Knipper, Hans F Fuchs, Hakan Alakus, et al.
International Journal of Molecular Sciences|September 9, 2023
Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor MicroenvironmentKarl Knipper, Su Ir Lyu, Alexander Quaas, et al.
BMC Cancer|November 27, 2025
MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targetsKarl Knipper, Christiane J Bruns, Felix C Popp, et al.
Cancers|April 13, 2023
Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaKarl Knipper, Alexander I Damanakis, Yue Zhao, et al.
Cancers|November 27, 2025
Loss of Argininosuccinate Synthetase-1 (ASS1) Occurs in Esophageal Adenocarcinoma and Represents a Promising Biomarker for Therapy with PegargiminaseKarl Knipper, Su Ir Lyu, Eleni Tzitzili, et al.
Oncology Letters|August 30, 2024
Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: A retrospective, single‑center cohort studySu Ir Lyu, Adrian Georg Simon, Jin-On Jung, et al.
Journal of Cancer Research and Clinical Oncology|March 27, 2023
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survivalSu Ir Lyu, Thaddaeus Krey, Alexander I Damanakis, et al.
BMC Cancer|July 17, 2023
High NANOG expression correlates with worse patients' survival in esophageal adenocarcinomaKarl Knipper, Alexander I Damanakis, Su Ir Lyu, et al.
Oral Oncology|January 5, 2025
High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinomaSu Ir Lyu, Caroline Fretter, Hans Nikolaus Caspar Eckel, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Chirurgie (Heidelberg, Germany)|September 16, 2022
[56/m-Dysphagia and loss of weight : Preparation for the medical specialist examination: part 11]Karl Knipper, Thomas Schmidt, Christiane J Bruns
Chirurgie (Heidelberg, Germany)|January 26, 2023
[Hereditary diffuse gastric cancer]Karl Knipper, Hans F Fuchs, Hakan Alakus, et al.
International Journal of Molecular Sciences|September 9, 2023
Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor MicroenvironmentKarl Knipper, Su Ir Lyu, Alexander Quaas, et al.
BMC Cancer|November 27, 2025
MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targetsKarl Knipper, Christiane J Bruns, Felix C Popp, et al.
Cancers|April 13, 2023
Specific Subtypes of Carcinoma-Associated Fibroblasts Are Correlated with Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaKarl Knipper, Alexander I Damanakis, Yue Zhao, et al.
Cancers|November 27, 2025
Loss of Argininosuccinate Synthetase-1 (ASS1) Occurs in Esophageal Adenocarcinoma and Represents a Promising Biomarker for Therapy with PegargiminaseKarl Knipper, Su Ir Lyu, Eleni Tzitzili, et al.
Oncology Letters|August 30, 2024
Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: A retrospective, single‑center cohort studySu Ir Lyu, Adrian Georg Simon, Jin-On Jung, et al.
Journal of Cancer Research and Clinical Oncology|March 27, 2023
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survivalSu Ir Lyu, Thaddaeus Krey, Alexander I Damanakis, et al.
BMC Cancer|July 17, 2023
High NANOG expression correlates with worse patients' survival in esophageal adenocarcinomaKarl Knipper, Alexander I Damanakis, Su Ir Lyu, et al.
Oral Oncology|January 5, 2025
High expression of H2AX/γ-H2AX is associated with distinct biological pathway alterations and shorter survival in oropharyngeal squamous cell carcinomaSu Ir Lyu, Caroline Fretter, Hans Nikolaus Caspar Eckel, et al.
Pageof 3